跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 5,751 条关于
“Dispatch Bio”
全部
5,751
临床试验
2,616
药物
1,023
机构
270
资讯
1,842
去年
Dispatch Bio Emerges with $216M to Develop Universal Solid Tumor Immunotherapy
上个月
Dispatch Bio Doses First Patient in Phase 1 Trial of DISP-10, a Novel Synthetic-Antigen CAR T Immunotherapy for Advanced GI Cancers, Secures FDA Fast Track Designation
去年
Anatara Lifesciences Nears Completion of Stage 2 Recruitment for GaRP-IBS Trial
2年前
Emyria's MDMA-Assisted Therapy Shows Promise in PTSD Interim Trial Results
2年前
Biotron's BIT225 Phase 2 Trial for COVID-19 Meets Safety Endpoint but Fails to Show Efficacy
去年
Arnatar Therapeutics Emerges with $52M to Develop First-in-Class RNA Therapy for Rare Genetic Disease
上个月
Vertex CEO Reshma Kewalramani Leads CRISPR Revolution as Pharma's Top Women Executives Reshape the Industry
去年
STGen Bio's Songdo Plant Secures FDA cGMP Approval, Expanding Global Reach
去年
Tolerance Bio Partners with ZipCode Bio to Develop Targeted Thymus Therapeutics for Immune Aging
去年
Mabwell and Aditum Bio Launch Kalexo Bio to Advance Novel siRNA Therapy for Cardiovascular Disease
第 1 页,共 185 页
上一页
下一页